First Boston Pharma acquires NutraMax Products

GLOUCESTER, Mass. First Boston Pharma on Wednesday announced its acquisition of NutraMax Products, a contract manufacturer of solid dose and soft chew pharmaceuticals and supplements.

The company will now be known as First Boston Pharma. Leading the First Boston Pharma organization will be Mario Medri, the company stated.

“The acquisition by [Medri] and the First Boston Pharma Group will propel the company further and faster along the trajectory we are on, particularly with designer products for pharmaceuticals and supplement markets,” stated Rodney Plunkett, First Boston Pharma EVP. “To have the industry's foremost innovator leading First Boston Pharma into the future is an exciting prospect for us and for our customers.”

The acquisition of NutraMax by First Boston Pharma will provide the necessary resources for the company to pursue its strategy of innovation in the over-the-counter drugs and supplements categories.

“One of our key strategies is to move to a supply base integrity model, which gives our customers the differentiated products they need, when they want them,” Medri said.

NutraMax Products should not be confused with the Maryland-based company with a similar name — Nutramax Laboratories — which distributes a number of supplement products, including the glucosamine/chondroitin product Cosamin DS.